{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:10:06Z","timestamp":1795108206113,"version":"4.10.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Health Key Research and Development Project","award":["ZD2022032"],"award-info":[{"award-number":["ZD2022032"]}]},{"name":"Suzhou Medical and Health Science Technology Innovation Project","award":["SKY2022146"],"award-info":[{"award-number":["SKY2022146"]}]},{"name":"Suzhou Science and Technology Bureau Clinical Trial Institution Capability Improvement Project","award":["SLT2023035"],"award-info":[{"award-number":["SLT2023035"]}],"id":[{"id":"https:\/\/ror.org\/02vpk4745","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03639-z","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:16:35Z","timestamp":1759914995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Single-cell sequencing reveals distinct peripheral immune responses in anti-MDA5 antibody positive dermatomyositis with rapidly progressive interstitial lung disease"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-7745","authenticated-orcid":false,"given":"Chenghua","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenke","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-9601","authenticated-orcid":false,"given":"Zhichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"1","key":"3639_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol. 2024;20(1):48\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"18","key":"3639_CR2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1097\/CM9.0000000000002049","volume":"135","author":"C Weng","year":"2022","unstructured":"Weng C, Liu Z. Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis. Chin Med J. 2022;135(18):2188\u201390.","journal-title":"Chin Med J"},{"issue":"3","key":"3639_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40744-023-00540-6","volume":"10","author":"C Weng","year":"2023","unstructured":"Weng C, Ding Z, Zhou Y, Yang Q, Xue L, Zhang L, et al. Clinical characteristics of dermatomyositis with interstitial lung disease: a retrospective case-control study. Rheumatol Ther. 2023;10(3):635\u201348.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"3639_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571\u20136.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3639_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 december 2018. Neuromuscular disorders\u202f: NMD. 2020;30(1):70\u201392.","journal-title":"Neuromuscular disorders : NMD"},{"issue":"1","key":"3639_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/BOR.0000000000000979","volume":"36","author":"M Yasui","year":"2024","unstructured":"Yasui M, Iwamoto T, Furuta S. New therapies in anti-MDA5 antibody-positive dermatomyositis. Curr Opin Rheumatol. 2024;36(1):61\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"3639_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152500","volume":"68","author":"C Weng","year":"2024","unstructured":"Weng C, Zhou Y, Zhang L, Wang G, Ding Z, Xue L, et al. Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: a systematic review and network meta-analysis. Semin Arthritis Rheum. 2024;68:152500.","journal-title":"Semin Arthritis Rheum"},{"key":"3639_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152231","volume":"62","author":"H Xie","year":"2023","unstructured":"Xie H, Zhang D, Wang Y, Shi Y, Yuan Y, Wang L, et al. Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: a meta-analysis and systematic review. Semin Arthritis Rheum. 2023;62:152231.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3639_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/joim.13607","volume":"293","author":"Q Jin","year":"2023","unstructured":"Jin Q, Fu L, Yang H, Chen X, Lin S, Huang Z, et al. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. J Intern Med. 2023;293(4):494\u2013507.","journal-title":"J Intern Med"},{"issue":"1","key":"3639_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AG Dias Junior","year":"2019","unstructured":"Dias Junior AG, Sampaio NG, Rehwinkel J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol. 2019;27(1):75\u201385.","journal-title":"Trends Microbiol"},{"issue":"11","key":"3639_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102666","volume":"19","author":"E De Lorenzis","year":"2020","unstructured":"De Lorenzis E, Natalello G, Gigante L, Verardi L, Bosello SL, Gremese E. What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Autoimmun Rev. 2020;19(11):102666.","journal-title":"Autoimmun Rev"},{"key":"3639_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01618-2020","author":"M Giannini","year":"2020","unstructured":"Giannini M, Ohana M, Nespola B, Zanframundo G, Geny B, Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.01618-2020.","journal-title":"Eur Respir J"},{"issue":"D1","key":"3639_CR13","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. Cell marker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3639_CR14","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/rheumatology\/kead597","volume":"63","author":"J He","year":"2024","unstructured":"He J, Liu Z, Cao Y, Zhang X, Yi C, Zhou Y, et al. Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation-associated gene 5 dermatomyositis. Rheumatology (Oxford). 2024;63(8):2284\u201394.","journal-title":"Rheumatology (Oxford)"},{"key":"3639_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117321","volume":"543","author":"S Lin","year":"2023","unstructured":"Lin S, Zhang Y, Cao Z, Xu Y, Jin Q, Chen X, et al. Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis. Clin Chim Acta. 2023;543:117321.","journal-title":"Clin Chim Acta"},{"key":"3639_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845988","volume":"13","author":"Y Zuo","year":"2022","unstructured":"Zuo Y, Ye L, Chen F, Shen Y, Lu X, Wang G, et al. Different multivariable risk factors for rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis and anti-synthetase syndrome. Front Immunol. 2022;13:845988.","journal-title":"Front Immunol"},{"issue":"5","key":"3639_CR17","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bjd.16917","volume":"180","author":"SH Zhang","year":"2019","unstructured":"Zhang SH, Zhao Y, Xie QB, Jiang Y, Wu YK, Yan B. Aberrant activation of the type i interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis. Br J Dermatol. 2019;180(5):1090\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"3639_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34145-4","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye Y, Chen Z, Jiang S, Jia F, Li T, Lu X, et al. Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications. Nat Commun. 2022;13(1):6458.","journal-title":"Nat Commun"},{"key":"3639_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513\u201345.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"3639_CR20","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2015.04.047","volume":"11","author":"H Oshiumi","year":"2015","unstructured":"Oshiumi H, Miyashita M, Okamoto M, Morioka Y, Okabe M, Matsumoto M, et al. Ddx60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation. Cell Rep. 2015;11(8):1193\u2013207.","journal-title":"Cell Rep"},{"key":"3639_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1176177","volume":"14","author":"L Villamayor","year":"2023","unstructured":"Villamayor L, L\u00f3pez-Garc\u00eda D, Rivero V, Mart\u00ednez-Sobrido L, Nogales A, DeDiego ML. The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling. Front Microbiol. 2023;14:1176177.","journal-title":"Front Microbiol"},{"key":"3639_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01839-19","author":"ML DeDiego","year":"2019","unstructured":"DeDiego ML, Nogales A, Martinez-Sobrido L, Topham DJ. Interferon-induced protein 44 interacts with cellular FK506-binding protein 5, negatively regulates host antiviral responses, and supports virus replication. MBio. 2019. https:\/\/doi.org\/10.1128\/mBio.01839-19.","journal-title":"MBio"},{"key":"3639_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01159-19","author":"ML DeDiego","year":"2019","unstructured":"DeDiego ML, Martinez-Sobrido L, Topham DJ. Novel functions of IFI44L as a feedback regulator of host antiviral responses. J Virol. 2019. https:\/\/doi.org\/10.1128\/JVI.01159-19.","journal-title":"J Virol"},{"key":"3639_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1105309","volume":"14","author":"L Villamayor","year":"2023","unstructured":"Villamayor L, Rivero V, L\u00f3pez-Garc\u00eda D, Topham DJ, Mart\u00ednez-Sobrido L, Nogales A, et al. Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation. Front Immunol. 2023;14:1105309.","journal-title":"Front Immunol"},{"issue":"11","key":"3639_CR25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock KL, Reits E, Neefjes J. Present yourself! by MHC class I and MHC class II molecules. Trends Immunol. 2016;37(11):724\u201337.","journal-title":"Trends Immunol"},{"issue":"23","key":"3639_CR26","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.3748\/wjg.15.2855","volume":"15","author":"EJ Beswick","year":"2009","unstructured":"Beswick EJ, Reyes VE. CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract. World J Gastroenterol. 2009;15(23):2855\u201361.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3639_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.sbi.2005.01.013","volume":"15","author":"M Halic","year":"2005","unstructured":"Halic M, Beckmann R. The signal recognition particle and its interactions during protein targeting. Curr Opin Struct Biol. 2005;15(1):116\u201325.","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"3639_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01285-4","volume":"8","author":"L Jiao","year":"2023","unstructured":"Jiao L, Liu Y, Yu XY, Pan X, Zhang Y, Tu J, et al. Ribosome biogenesis in disease: new players and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):15.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3639_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc2819","volume":"10","author":"J van Riggelen","year":"2010","unstructured":"van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010;10(4):301\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3639_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrm3742","volume":"15","author":"AG Matera","year":"2014","unstructured":"Matera AG, Wang Z. A day in the life of the spliceosome. Nat Rev Mol Cell Biol. 2014;15(2):108\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3639_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah K, Al-Haidari A, Sun J, Kazi JU. T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther. 2021;6(1):412.","journal-title":"Signal Transduct Target Ther"},{"issue":"Suppl 4","key":"3639_CR32","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","volume":"37","author":"Y Yarden","year":"2001","unstructured":"Yarden Y. The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer (Oxford, England\u202f: 1990). 2001;37(Suppl 4):S3-8.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"key":"3639_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121766","author":"SS Noh","year":"2023","unstructured":"Noh SS, Shin HJ. Role of virus-induced EGFR trafficking in proviral functions. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13121766.","journal-title":"Biomolecules"},{"issue":"12","key":"3639_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011;11(12):823\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3639_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1905-z","volume":"21","author":"L Zhang","year":"2019","unstructured":"Zhang L, Xia Q, Li W, Peng Q, Yang H, Lu X, et al. The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis. Arthritis Res Ther. 2019;21(1):131.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3639_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02698-x","volume":"19","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhang L, Wang J, Zhang M, Song Z, Ni B, et al. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med. 2021;19(1):35.","journal-title":"J Transl Med"},{"key":"3639_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1060438","volume":"13","author":"M Shojaei","year":"2022","unstructured":"Shojaei M, Shamshirian A, Monkman J, Grice L, Tran M, Tan CW, et al. IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. Front Immunol. 2022;13:1060438.","journal-title":"Front Immunol"},{"issue":"4","key":"3639_CR38","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","volume":"17","author":"D Brandt","year":"2018","unstructured":"Brandt D, Hedrich CM. TCR\u03b1\u03b2(+)CD3(+)CD4(-)CD8(-) (double negative) T cells in autoimmunity. Autoimmun Rev. 2018;17(4):422\u201330.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3639_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/BOR.0000000000000778","volume":"33","author":"H Li","year":"2021","unstructured":"Li H, Tsokos GC. Double-negative T cells in autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):163\u201372.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3639_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tim.2022.07.008","volume":"31","author":"M Boeren","year":"2023","unstructured":"Boeren M, Meysman P, Laukens K, Ponsaerts P, Ogunjimi B, Delputte P. T cell immunity in HSV-1- and VZV-infected neural ganglia. Trends Microbiol. 2023;31(1):51\u201361.","journal-title":"Trends Microbiol"},{"issue":"9","key":"3639_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.it.2024.07.005","volume":"45","author":"T Inoue","year":"2024","unstructured":"Inoue T, Baba Y, Kurosaki T. BCR signaling in germinal center B cell selection. Trends Immunol. 2024;45(9):693\u2013704.","journal-title":"Trends Immunol"},{"key":"3639_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010003","author":"M Yabas","year":"2015","unstructured":"Yabas M, Elliott H, Hoyne GF. The role of alternative splicing in the control of immune homeostasis and cellular differentiation. Int J Mol Sci. 2015. https:\/\/doi.org\/10.3390\/ijms17010003.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3639_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tim.2018.11.004","volume":"27","author":"U Ashraf","year":"2019","unstructured":"Ashraf U, Benoit-Pilven C, Lacroix V, Navratil V, Naffakh N. Advances in analyzing virus-induced alterations of host cell splicing. Trends Microbiol. 2019;27(3):268\u201381.","journal-title":"Trends Microbiol"},{"key":"3639_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1619","author":"HD Hoang","year":"2021","unstructured":"Hoang HD, Neault S, Pelin A, Alain T. Emerging translation strategies during virus-host interaction. WIREs RNA. 2021. https:\/\/doi.org\/10.1002\/wrna.1619.","journal-title":"WIREs RNA"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03639-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03639-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03639-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:10:05Z","timestamp":1761646205000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03639-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3639"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03639-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Professor Liu Zhichun's email address has been updated to zcliurheu@suda.edu.cn.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University (ID: LK2024092) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}